Please assess the completion status of the following clinical trial:

Trial Title: Effectiveness of Artemether-Lumefantrine for Malaria Treatment of Children at Community Level in Tanzania

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Aged \<5 years~2. Weight \>5 kg~3. Suffering from acute uncomplicated P. falciparum malaria confirmed by RDT. Later microscopy using Giemsa-stained thick film will be made to ensure asexual parasite density of 2000 to 200 000 parasites/µL~4. Having a history of fever in the preceding 24 h~5. Able to ingest tablets orally~6. Willing and able to attend stipulated follow-up visits~7. With written informed consent from parent/guardian for children to participate in the trial.~Exclusion Criteria:~Presenting with any of the following danger signs of severe malaria:~1. Convulsions (\>1 episode within previous 24 hours)~2. Lethargic/unconscious

- Gender: ALL
- Minimum Age: None
- Maximum Age: 5 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).